Addex Therapeutics Ltd
ADXN | NASDAQ
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.32
-$0.21 (-5.95%)
Pre-market:
Sep 22, 2026, 4:31 AM ET
TTM Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 74.04K | 66.35K | 67.61K | 91.72K | 170.62K | 404.1K | 556.05K | 829.94K | 1.35M | 1.61M | 2.05M | 2.13M | 1.69M | 1.42M | 1.23M | 1.5M | 2.31M | 2.92M | 4.34M | 3.68M | 3.55M |
Cost of Revenue | 270.58K | 234.45K | 234.45K | 234.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -196.55K | -168.11K | -166.85K | -142.73K | 170.62K | 404.1K | 556.05K | 829.94K | 1.35M | 1.61M | 2.05M | 2.13M | 1.69M | 1.42M | 1.23M | 1.5M | 2.31M | 2.92M | 4.34M | 3.68M | 3.55M |
Operating Income | -2.69M | -2.81M | -2.48M | -2.41M | -2.57M | -2.76M | -4.99M | -5.12M | -4.62M | -4.2M | -5.01M | -8.43M | -15.13M | -20.52M | -21.3M | -20.71M | -18.12M | -15.51M | -13.11M | -12.65M | -11.12M |
Interest Income | 3 | 3 | -12 | 90 | 1.59K | 9.17K | 22.31K | 35.87K | 47.71K | 63.96K | 76.18K | 66.13K | 52.98K | 29.25K | 4.66K | 2.29K | 3.81K | 532.87K | 533.37K | 533.41K | 542.53K |
Pretax Income | -7.08M | -6.84M | -6.2M | -6.15M | -5.65M | -4.91M | -6.58M | -5.76M | -4.82M | -4.46M | -5.25M | -8.65M | -15.35M | -20.8M | -21.58M | -21.07M | -18.54M | -15.35M | -13.05M | -12.77M | -11.19M |
Net Income | -6.97M | -6.73M | -6.1M | -6.05M | 8.67M | 7.06M | 5.4M | 4.32M | -11.24M | -10.56M | -11.35M | -12.84M | -17.39M | -20.8M | -21.58M | -21.07M | -18.54M | -15.35M | -13.05M | -12.77M | -11.19M |
Selling & General & Admin | 1.83M | 1.89M | 1.58M | 1.46M | 1.55M | 1.68M | 3.12M | 3.26M | 3.34M | 3.28M | 1.33M | 3.25M | 4.76M | 7.3M | 8.04M | 7.7M | 7.45M | 5.72M | 5.86M | 5.04M | 4.78M |
Research & Development | 167K | 190.19K | 180.1K | 172.69K | 288.66K | 435.19K | 895.72K | 1.24M | 1.28M | 1.3M | 6.59M | 7.91M | 12.36M | 14.67M | 12.42M | 12.49M | 11.54M | 11.78M | 13.35M | 13.52M | 12.11M |
Other Expenses | 495.45K | 568.37K | 553.5K | 633.71K | 902.31K | 1.05M | 1.53M | 1.45M | 1.34M | 1.23M | -861.13K | -594.52K | -303.05K | -22.52K | 2.07M | 2.02M | 1.44M | 917.99K | -1.75M | -2.23M | -2.22M |
Operating Expenses | 2.49M | 2.65M | 2.31M | 2.26M | 2.74M | 3.16M | 5.55M | 5.95M | 5.96M | 5.81M | 7.06M | 10.56M | 16.81M | 21.94M | 22.52M | 22.21M | 20.43M | 18.42M | 17.45M | 16.34M | 14.67M |
Interest Expense | 4.94K | 2.42K | 3.34K | 3.45K | 3.48K | 3.55K | 10.42K | 13.33K | 16.3K | 16.3K | 15.71K | 18.59K | 27.09K | 48.9K | 50.47K | 54.08K | 64.69K | 63.01K | 63.94K | 66.49K | 61.68K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.76M | 2.88M | 2.55M | 2.5M | 2.74M | 3.16M | 5.55M | 5.95M | 5.96M | 5.81M | 7.06M | 10.56M | 16.81M | 21.94M | 22.52M | 22.21M | 20.43M | 18.42M | 17.45M | 16.34M | 14.67M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.43M | 1.19M | 938.98K | 721.04K | 819.54K | 815.2K | 812.79K | 812.79K | 812.79K | 793.64K | 643.99K | 601.57K | 510.41K | 497.46K | 398.21K | 312.23K | 315.79K | 289.81K | 284.35K | 283.83K | 279.33K |
Shares Outstanding (Diluted) | 1.43M | 1.19M | 938.98K | 767.15K | 819.54K | 815.2K | 812.79K | 812.79K | 812.79K | 793.64K | 643.99K | 601.57K | 510.41K | 497.46K | 398.21K | 312.23K | 315.79K | 289.81K | 284.35K | 283.83K | 279.33K |
EPS (Basic) | -6.96 | -7.56 | -7.50 | -7.72 | 10.44 | 8.44 | 6.31 | 4.13 | -15.60 | -16.80 | -20.40 | -26.40 | -45.60 | -58.80 | -67.20 | -69.60 | -63.60 | -55.20 | -49.20 | -50.40 | -48 |
EPS (Diluted) | -6.80 | -7.40 | -7.34 | -7.56 | 10.44 | 8.44 | 6.31 | 4.13 | -15.60 | -16.80 | -20.40 | -26.40 | -45.60 | -58.80 | -67.20 | -69.60 | -63.60 | -55.20 | -49.20 | -50.40 | -48 |
EBITDA | -7.06M | -6.83M | -6.17M | -6.06M | -5.45M | -4.65M | -6.25M | -5.41M | -4.51M | -4.14M | -4.94M | -8.33M | -15.01M | -20.43M | -21.2M | -20.67M | -18.13M | -14.94M | -12.64M | -12.34M | -10.76M |
EBIT | -7.08M | -6.84M | -6.2M | -6.15M | -5.64M | -4.91M | -6.57M | -5.75M | -4.81M | -4.45M | -5.24M | -8.64M | -15.32M | -20.76M | -21.53M | -21.01M | -18.47M | -15.29M | -12.99M | -12.7M | -11.13M |
Depreciation & Amortization | 16.17K | 8.47K | 30.16K | 81.61K | 191.88K | 260.12K | 315.7K | 337.51K | 300.53K | 305.95K | 302.22K | 304.15K | 312.09K | 323.14K | 330.46K | 340.88K | 345.8K | 347.61K | 351.72K | 362.99K | 371.24K |
Add to Watchlist
Select watchlists to add or remove ADXN